These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19884495)

  • 1. Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure.
    Tsai YS; Xu L; Smithies O; Maeda N
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19084-9. PubMed ID: 19884495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes.
    Fujiki K; Kano F; Shiota K; Murata M
    BMC Biol; 2009 Jul; 7():38. PubMed ID: 19589179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-302a inhibits adipogenesis by suppressing peroxisome proliferator-activated receptor γ expression.
    Jeong BC; Kang IH; Koh JT
    FEBS Lett; 2014 Sep; 588(18):3427-34. PubMed ID: 25109777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
    Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
    Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.
    Ketsawatsomkron P; Keen HL; Davis DR; Lu KT; Stump M; De Silva TM; Hilzendeger AM; Grobe JL; Faraci FM; Sigmund CD
    Hypertension; 2016 Jan; 67(1):214-22. PubMed ID: 26597823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
    Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
    Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.
    Shrivastav S; Kino T; Cunningham T; Ichijo T; Schubert U; Heinklein P; Chrousos GP; Kopp JB
    Mol Endocrinol; 2008 Feb; 22(2):234-47. PubMed ID: 17932108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
    Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
    Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-Activated Receptor γ Level Contributes to Structural Integrity and Component Production of Elastic Fibers in the Aorta.
    Tai HC; Tsai PJ; Chen JY; Lai CH; Wang KC; Teng SH; Lin SC; Chang AY; Jiang MJ; Li YH; Wu HL; Maeda N; Tsai YS
    Hypertension; 2016 Jun; 67(6):1298-308. PubMed ID: 27045031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells.
    Desch M; Schreiber A; Schweda F; Madsen K; Friis UG; Weatherford ET; Sigmund CD; Sequeira Lopez ML; Gomez RA; Todorov VT
    Hypertension; 2010 Mar; 55(3):660-6. PubMed ID: 20065157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications].
    Gacka M; Adamiec R
    Postepy Hig Med Dosw (Online); 2004; 58():483-9. PubMed ID: 15765009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.
    Freedman BD; Lee EJ; Park Y; Jameson JL
    J Biol Chem; 2005 Apr; 280(17):17118-25. PubMed ID: 15716267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma expression in peripheral blood mononuclear cells and angiopoietin-like protein 4 levels in obese children and adolescents.
    Sadeghabadi ZA; Nourbakhsh M; Alaee M; Larijani B; Razzaghy-Azar M
    J Endocrinol Invest; 2018 Feb; 41(2):241-247. PubMed ID: 28733963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.
    Halabi CM; Beyer AM; de Lange WJ; Keen HL; Baumbach GL; Faraci FM; Sigmund CD
    Cell Metab; 2008 Mar; 7(3):215-26. PubMed ID: 18316027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic PPARγ deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility.
    Gilardi F; Winkler C; Quignodon L; Diserens JG; Toffoli B; Schiffrin M; Sardella C; Preitner F; Desvergne B
    Metabolism; 2019 Jun; 95():8-20. PubMed ID: 30878493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
    Takasawa K; Kubota N; Terauchi Y; Kadowaki T
    Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.
    Ruschke K; Fishbein L; Dietrich A; Klöting N; Tönjes A; Oberbach A; Fasshauer M; Jenkner J; Schön MR; Stumvoll M; Blüher M; Mantzoros CS
    Eur J Endocrinol; 2010 Mar; 162(3):515-23. PubMed ID: 19966034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic variation of PPARgamma in humans.
    Meirhaeghe A; Amouyel P
    Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.